Home
Drugs
Docetaxel
Clinical Trials

Clinical Trials Related to Docetaxel

Related studies linked through entity extraction aliases.

To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study

Status: UNKNOWN
Phase: NA

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

Status: COMPLETED
Phase: PHASE1

Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer

Status: RECRUITING
Phase: PHASE2

Study of Novel Treatment Combinations in Patients With Lung Cancer

Status: RECRUITING
Phase: PHASE2

SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE3

A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors

Status: COMPLETED
Phase: PHASE1

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer

Status: TERMINATED
Phase: PHASE2

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

Status: COMPLETED
Phase: PHASE2

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Status: UNKNOWN
Phase: PHASE1

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Status: RECRUITING
Phase: PHASE2

Intravesical BCG vs GEMDOCE in NMIBC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

Status: RECRUITING
Phase: NA

Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma

Status: TERMINATED
Phase: PHASE2

The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer

Status: RECRUITING
Phase: PHASE2

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)

Status: COMPLETED
Phase: PHASE2